thalidomide has been researched along with Anaphylactic Reaction in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Finally, administration of the immunomodulator pomalidomide suppressed passive systemic anaphylaxis of mice." | 3.88 | The effect of PU.1 knockdown on gene expression and function of mast cells. ( Fujigaki, I; Kageyama, A; Kasakura, K; Nishiyama, C; Oda, Y; Ogawa, H; Okumura, K; Yashiro, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oda, Y | 1 |
| Kasakura, K | 1 |
| Fujigaki, I | 1 |
| Kageyama, A | 1 |
| Okumura, K | 1 |
| Ogawa, H | 1 |
| Yashiro, T | 1 |
| Nishiyama, C | 1 |
1 other study available for thalidomide and Anaphylactic Reaction
| Article | Year |
|---|---|
The effect of PU.1 knockdown on gene expression and function of mast cells.
Topics: Anaphylaxis; Animals; Cells, Cultured; Dendritic Cells; Gene Knockdown Techniques; HEK293 Cells; Hum | 2018 |